Newsroom

01.03.2018
Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million

Lachen, Switzerland, March 1st, 2018: Over the last six years, the Octapharma Group has accomplished...

more

22.01.2018
Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of fina...

more

Career

Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities 

Career

Annual Report 2017

www.annualreport.octapharma.com